Soleno Therapeutics, Inc. - stock earnings
SLNO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -11.3 million USD | ? USD |
| 2023Q3 | -10.9 million USD | ? USD |
| 2023Q2 | -8.5 million USD | ? USD |
| 2023Q1 | -8.4 million USD | ? USD |
| 2022Q4 | -3.7 million USD | ? USD |
| 2022Q3 | -6.3 million USD | ? USD |
| 2022Q2 | -7.8 million USD | ? USD |
| 2022Q1 | -3.9 million USD | ? USD |
| 2021Q4 | -2.8 million USD | ? USD |
| 2021Q3 | -8.1 million USD | ? USD |
| 2021Q2 | -11.0 million USD | ? USD |
| 2021Q1 | -9.0 million USD | ? USD |
| 2020Q4 | -2.9 million USD | ? USD |
| 2020Q3 | -8.5 million USD | ? USD |
| 2020Q2 | -7.4 million USD | ? USD |
| 2020Q1 | -5.9 million USD | ? USD |
| 2019Q4 | -14.6 million USD | ? USD |
| 2019Q3 | 889000 USD | ? USD |
| 2019Q2 | -10.0 million USD | ? USD |
| 2019Q1 | -7.0 million USD | ? USD |
| 2018Q4 | 263000 USD | ? USD |
| 2018Q3 | -2.7 million USD | ? USD |
| 2018Q2 | -7.6 million USD | ? USD |
| 2018Q1 | -5.0 million USD | 734.9 million USD |
| 2017Q4 | -5.0 million USD | -243979 USD |
| 2017Q3 | -3.8 million USD | -208000 USD |
| 2017Q2 | -4.0 million USD | 1000 USD |
| 2017Q1 | -2.9 million USD | 265000 USD |
| 2016Q4 | -2.6 million USD | 283788 USD |
| 2016Q3 | -2.8 million USD | 329000 USD |
| 2016Q2 | -3.5 million USD | 391000 USD |
| 2016Q1 | -3.2 million USD | 447000 USD |
| 2015Q4 | -2.8 million USD | 241555 USD |
| 2015Q3 | -3.3 million USD | 92000 USD |
| 2015Q2 | 1.9 million USD | 32000 USD |
| 2015Q1 | -11.7 million USD | 22000 USD |
| 2014Q4 | -7.9 million USD | ? USD |
| 2014Q3 | -2.4 million USD | ? USD |
| 2014Q2 | -2.8 million USD | ? USD |
| 2014Q1 | -833865 USD | ? USD |
| 2013Q4 | -974243 USD | 3.0 million USD |
| 2013Q3 | -1.6 million USD | 3.0 million USD |
| 2013Q2 | -2.2 million USD | 3.0 million USD |
| 2013Q1 | 1.0 million USD | 3.0 million USD |
SLNO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -39.0 million USD | ? USD |
| 2022 | -20.3 million USD | ? USD |
| 2021 | -29.6 million USD | ? USD |
| 2020 | -15.4 million USD | ? USD |
| 2019 | -35.9 million USD | ? USD |
| 2018 | -13.3 million USD | ? USD |
| 2017 | -15.7 million USD | -1.6 billion USD |
| 2016 | -12.1 million USD | 1.5 million USD |
| 2015 | -15.9 million USD | 387555 USD |
| 2014 | -13.9 million USD | ? USD |
| 2013 | -3.7 million USD | 3.0 million USD |
| 2012 | -6.5 million USD | ? USD |
SLNO
Price: $45.12
52 week price:
Earnings Per Share: -2.36 USD
P/E Ratio: -15.10
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 110100
Ebitda: -13.8 millionMarket Capitalization: 1.3 billion